Understanding and Overcoming Immunosuppression Shaped by Cancer Stem Cells
Open Access
- 5 July 2023
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 83 (13) , 2096-2104
Abstract
Use of immunotherapy in recent years has revolutionized cancer treatment for certain types of cancers. However, the broad utility of immunotherapy is limited because there are still many types of cancer that do not respond effectively. Failure of a cancer to respond is due, at least in part, to its phenotypic plasticity, a feature that is established by cancer stem cells (CSC) and their associated microenvironments. This article discusses the current understanding of CSC-mediated immune evasion and provides a prospective view on how researchers can better understand and overcome the intrinsic immune privilege of CSCs and the extrinsic immune-suppressive microenvironment shaped by them.Keywords
Funding Information
- Stowers Institute for Medical Research (SIMR-1004)
- NIDDK/NIAID (U01DK085507)
- National Computational Infrastructure (P30 CA168524)
This publication has 174 references indexed in Scilit:
- A restricted cell population propagates glioblastoma growth after chemotherapyNature, 2012
- Microenvironments Dictating Tumor Cell Dormancy2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Macrophage Diversity Enhances Tumor Progression and MetastasisCell, 2010
- Immunity, Inflammation, and CancerCell, 2010
- The Multifaceted Role of MTDH/AEG-1 in Cancer ProgressionClinical Cancer Research, 2009
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem CellsCell, 2009
- Immunosuppressive Strategies that are Mediated by Tumor CellsAnnual Review of Immunology, 2007
- Normal Stem Cells and Cancer Stem Cells: The Niche MattersCancer Research, 2006
- The Hallmarks of CancerCell, 2000